Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin.
about
Molecular mechanisms of HPV mediated neoplastic progressionThe Role of the DNA Damage Response throughout the Papillomavirus Life CycleHigh-risk human papillomavirus targets crossroads in immune signalingThe papillomavirus E1 helicase activates a cellular DNA damage response in viral replication fociPolo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidyNegative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9.Genomic instability and cancer: lessons learned from human papillomaviruses.Current trends in the etiology and diagnosis of HPV-related head and neck cancers.Claspin as a biomarker of human papillomavirus-related high grade lesions of uterine cervix.Human papillomavirus E7 induces rereplication in response to DNA damageβ-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H.Oxidative stress and HPV carcinogenesis.Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk virusesThe papillomavirus E7 proteins.Proteomics-based identification of VDAC1 as a tumor promoter in cervical carcinomaCDDO-Me reveals USP7 as a novel target in ovarian cancer cells.DNA damage response is hijacked by human papillomaviruses to complete their life cycleDesign stars: how small DNA viruses remodel the host nucleus.Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses.The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.Immortalization capacity of HPV types is inversely related to chromosomal instability.Modulation of the DNA damage response during the life cycle of human papillomaviruses.Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.Coronavirus infection induces DNA replication stress partly through interaction of its nonstructural protein 13 with the p125 subunit of DNA polymerase δ.The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes.Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis.Persistent infections and their relationship with selected oncologic and non-tumor pathologies.Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva.Human papillomavirus and genome instability: from productive infection to cancer
P2860
Q28070323-15BBBC0E-247E-4DA7-BE0D-43026ED71339Q28081948-E309F811-17BC-48FA-8D7B-DB0B70E33DC7Q28084802-EEAE3059-DF3E-4F41-AFCA-4B3F898A327FQ28740852-7496798F-413D-49BD-A3E5-0B04DAAD9076Q34144573-D4A902A8-BB46-414A-82BB-A7468C5CFC9EQ34147534-4BA98F3F-EF5B-4252-BB6A-37519B5C7A82Q34612265-B90BE91B-81D3-4A75-A8B6-94CA842F5A47Q35469459-E739D794-2A32-48D4-A626-E3E2973FC133Q36207038-7DB686BA-263E-40E0-AA11-82C56A83EC22Q36559551-35E5D6DB-5DF7-4AC1-AE48-5884B46C1B20Q36748405-05FABBAA-1C79-4474-8228-DCAD79265CCBQ36807150-A6EF0C46-9892-48E6-B59B-6E84F267E732Q36989890-9D29573E-2272-424F-9564-47C8AA8B4E74Q37198662-07DD310F-1FFE-40E4-B5EB-163BD9D8846FQ37588452-26DF7116-835C-420B-9089-7C7C83381FDEQ37718344-BC6CFAAC-FF54-4C7D-BCFA-9A61B3841730Q37724792-54CD7063-C833-4E13-B08B-BE08AB77DD97Q38023415-4817C548-05E6-4EAE-B398-4D69A51DA0A5Q38177526-97E08B88-A279-43E2-B270-EE67C22CFBB0Q38254163-F01EE618-64F2-4C4A-A47B-DC968AF16F7CQ38739045-D3E98652-24C5-4A23-B9CC-4D48D051B0B6Q39005827-40A0C226-EED3-4BAB-8238-61D908476469Q39090989-5F6D8FE6-3720-4D6E-94DC-747F9791DE9EQ39707460-3DBE8E2D-6530-48B7-9495-0E34CAC675D1Q40913003-0B82EA38-F3C4-43B2-B420-0D56A1F92C15Q41637438-78BE769A-72D3-4F28-94B4-C3C30CF83C80Q41669449-98BAF327-3293-4748-944A-24282BED7FB6Q41863345-71AAC4AB-1EB2-41CA-8F87-6DA7967A7471Q42997444-AB1C49E1-7F66-4D1B-9A66-892744EF86E8Q44634016-21DEB71D-9BD5-4670-961E-FE64F281625AQ58699202-188C0103-2873-4265-A9E0-F06338DF4D46
P2860
Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Human papillomavirus 16 E7 onc ...... oteolytic turnover of claspin.
@en
Human papillomavirus 16 E7 onc ...... oteolytic turnover of claspin.
@nl
type
label
Human papillomavirus 16 E7 onc ...... oteolytic turnover of claspin.
@en
Human papillomavirus 16 E7 onc ...... oteolytic turnover of claspin.
@nl
prefLabel
Human papillomavirus 16 E7 onc ...... oteolytic turnover of claspin.
@en
Human papillomavirus 16 E7 onc ...... oteolytic turnover of claspin.
@nl
P2093
P2860
P1433
P1476
Human papillomavirus 16 E7 onc ...... oteolytic turnover of claspin.
@en
P2093
Anette Duensing
Elizabeth E Hoskins
Elliot Cha
Kathryn Covella
Nicole Spardy
Stefan Duensing
Susanne I Wells
P2860
P304
P356
10.1158/0008-5472.CAN-09-0925
P407
P577
2009-08-25T00:00:00Z